The safety of a loading dose of intravenous antiepileptic drugs
SU Ying-ying,TIAN Fei,CHEN Wei-bi,GAO Ran,ZHANG Yun-zhou,ZHANG Yan,YE Hong,GAO Dai-quan,LIU Fang
DOI: https://doi.org/10.3760/cma.j.issn.1008-5734.2013.01.008
2013-01-01
Abstract:Objective To investigate the safety of a loading dose ofⅣantiepileptic drugs(AED) in the treatment of adult patients with generalized convulsive status epilepticus(GCSE).Methods A method for the analysis of pooled data was adopted.The results from the two prospective randomized controlled trials(RCTs) performed by Xuanwu Hospital from January 2007 to January 2010 and from June 2010 to May 2012 were collected.The clinical data were analyzed and compared among the patients in the diazepam group,the diazepam and subsequent valproate group,and the diazepam and subsequent phenobarbital group.A loading dose of IV diazepam(0.2 mg/kg,5 mg/min) was as first-line AED treatment for all patients in the 3 groups.Second-line AED treatment were as follows:in the diazepam group, a loading dose ofⅣdiazepam(0.2 mg/kg,5mg/min) was given,then a maintenance dose ofⅣdiazepam (4.0 mg/h,increase by 1.0μg/kg every 3 minutes) was given via a pump.In the diazepam subsequent valproate group,a loading dose ofⅣdiazepam 30 mg/kg,6 mg/(kg·min) was given,then a maintenance dose ofⅣvalproate 1-2 mg/(kg·h) was given via a pump.In the diazepam subsequent phenobarbital group,a loading dose of IV phenobarbital(20 mg/kg,50 mg/min) was given,then a maintenance dose ofⅣphenobarbital(100 mg/6 h,50 mg/min) was given.The second-line AED treatment should be continued until 24 hours after epileptic seizure stopped,then the dosage was gradually reduced.The patients should be closely monitored for reactions after drug administration.Results A total of 101 patients were enrolled in the study.They comprised 53 male and 48 female with mean age of(42±16) years.The diazepam group comprised 20 male and 18 female with mean age of(41±19) years.The diazepam and subsequent valproate group comprised 22 male and 18 female with mean age of(45±15) years.The diazepam and subsequent phenobarbital group comprised 11 male and 12 female with mean age of (41±14) years.There was no statistically significant difference among the baseline data of patients in the three groups.The termination rate of GCSE in the diazepam,diazepam and subsequent valproate,and diazepam and subsequent phenobarbital groups were 63.2%(24/38),57.5%(23/40) and 60.9%(14/ 23),respectively.The difference was not statistically significant(P = 0.902).There were 6 cases (15.8%) of adverse reactions in the diazepam group.The number of cases of respiratory depression, circulatory depression,and bone marrow depression were 2,3,and 1,respectively.There were 11 cases (27.5%) of adverse reactions in the diazepam and subsequent valproate group.The number of cases of slight hyperammonemia without hyperammonemia encephalopathy,mild abnormal liver function,and bone marrow depression were 8,2,and 1,respectively.There were 11 cases(47.8%) of adverse reactions in the diazepam and subsequent phenobarbital group.The number of cases of respiratory depression,circulation depression,mild abnormal liver function,and bone marrow depression were 3,2,5,and 1,respectively. The incidence of adverse reactions in the diazepam group was markedly lower than that in the diazepam and subsequent phenobarbital group(P = 0.033).The above-mentioned adverse symptoms could resolve after drug withdrawal and symptomatic treatment.Conclusions A loading dose ofⅣdiazepam orⅣvalproate orⅣphenobarbital are effective and safe in the treatment of adult patients with GCSE.The patient should be closely monitored for adverse reactions during the antiepileptic treatment,especially in the patients receiving diazepam combined with phenobarbital.Once adverse reactions developed,the drug should be stopped and symptomatic treatment should be given.